Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Employee Benefits Expense

v3.22.1
Employee Benefits Expense
 12 Months Ended
Dec. 31, 2021
Analysis of income and expense [abstract]  
Employee Benefits Expense Employee Benefits Expense
For the Year Ended December 31,
2021 2020 2019
$’000 $’000 $’000
Wages and salaries
 148,728  108,018  57,388 
Social security and pension contributions
 17,118  13,404  8,254 
Share-based compensation
 46,307  9,557  7,966 
Total
 212,153  130,979  73,608 
Of the total employee benefits expense, $62.3 million (2020:$34.5 million, 2019: $3.7 million) has been recognized in Cost of care delivery, $6.9 million (2020: $8.8 million, 2019: $7.2 million) in Platform & application expenses, $42.9 million (2020: $53.3 million, 2019: $36.6 million) in Research & development expenses, and $100.1 million (2020: $34.4 million, 2019: $26.0 million) in Sales, general & administrative expenses.
During 2021, the Group capitalized employee costs of $34.0 million (2020: $43.0 million, 2019: $36.0 million) as development costs.
Average Staff Numbers
For the Year Ended December 31,
2021 2020 2019
Engineers
 427  515  670 
Sales & marketing
 89  88  108 
Finance, HR & legal
 242  146  178 
Clinical operations
 856  586  476 
Clinicians
 959  773  124 
2,573  2,108  1,556